Trial intelligence / Profile preview

A Phase II Study of Metacavir Enteric-coated Capsules in the Treatment of Chronic Hepatitis B

CTR20131117Phase 2Completed

Sponsor
Nanjing Chang'ao Pharmaceutical Technology
Start
Aug 2014
Countries
1
01

Overview

A Phase 2 trial of metacavir in Chronic Hepatitis B (CHB), sponsored by Nanjing Chang'ao Pharmaceutical Technology. Started Aug 2014; status: completed.

02

Drugs

metacavir
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on CTR20131117.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131117.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call